Cytek Biosciences (CTKB) Gross Profit Growth (1y) (2021 - 2026)
Cytek Biosciences (CTKB) Gross Profit Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 15.59% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 17.10% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 10.88% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 12.38% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.54% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 20.50% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.82% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 4.20% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.95% |
| 10 | Cytek Biosciences | 602.64 Mn | 528.79 Mn | 28.34 Mn | 18.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.74% |
| Mar 31, 2026 | 5.44% |
| Dec 31, 2025 | -2.28% |
| Sep 30, 2025 | -5.01% |
| Jun 30, 2025 | -6.17% |
| Mar 31, 2025 | -12.41% |
| Dec 31, 2024 | 1.83% |
| Sep 30, 2024 | 6.72% |
| Jun 30, 2024 | -9.68% |
| Mar 31, 2024 | 9.39% |
| Dec 31, 2023 | 12.51% |
| Sep 30, 2023 | 1.18% |
| Jun 30, 2023 | 14.66% |
| Mar 31, 2023 | 4.27% |
| Dec 31, 2022 | 24.28% |
| Sep 30, 2022 | 26.25% |
| Jun 30, 2022 | 24.39% |
| Mar 31, 2022 | 39.29% |
| Dec 31, 2021 | 21.53% |
| Sep 30, 2021 | 36.25% |